(ALRIB) Riber S.A - Ratings and Ratios

Riber S.A. is a leading provider of molecular beam epitaxy (MBE) products and services to the semiconductor industry, catering to a diverse range of applications including power and RF electronics, lasers, IR detectors, display, passivation, materials, solar, and OEM. With a rich history dating back to 1964, the company has established itself as a pioneer in the field, offering a comprehensive suite of MBE systems, sources, heaters, manipulators, and accessories. Its product portfolio is designed to meet the complex needs of the semiconductor industry, enabling the production of high-quality compound semiconductors.

The companys expertise extends beyond its product offerings, with a strong focus on providing OEM components and systems, including point, valved, and linear sources, as well as process controllers and process control software. Ribers commitment to innovation and customer satisfaction has earned it a reputation as a trusted partner in the industry. With its headquarters in Bezons, France, Riber is well-positioned to serve the European and global markets.

Analyzing the , we observe that Ribers stock has been trading around €2.80, with a 20-day SMA of €2.69 and a 50-day SMA of €2.78, indicating a potential bullish trend. The ATR of 0.16 (5.67%) suggests moderate volatility. Considering the , Ribers market capitalization stands at €61.00M, with a P/E ratio of 14.56 and a forward P/E of 25.19, indicating a relatively high growth expectation. The RoE of 36.79% is impressive, highlighting the companys ability to generate strong returns on equity.

Based on the and , our forecast suggests that Ribers stock is poised for a potential uptrend. The stocks current price of €2.85 is likely to be supported by the SMA20 and SMA50 levels, while the SMA200 at €2.80 provides a longer-term bullish anchor. With a strong RoE and a relatively high P/E forward ratio, we expect Riber to continue delivering strong financial performance, driving the stock price higher. Our forecast predicts a potential target price of €3.20-€3.50 in the next 6-12 months, representing a 12-23% upside from current levels.